Paclitaxel (Intravenous Route)

3 imperatives to transform health care in America. You're invited to watch it live

Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Paclitaxel (Intravenous Route)

Drug Information provided by: Micromedex

US Brand Names

  • Nov-Onxol
  • Onxol
  • Paclitaxel Novaplus
  • Taxol

Description

Paclitaxel injection is used to treat advanced cancer of the ovaries, breast, non-small cell lung cancer, and Kaposi sarcoma. Kaposi sarcoma is a cancer of the skin and mucous membranes that is commonly found in patients with acquired immunodeficiency syndrome (AIDS).

Paclitaxel belongs to the group of medicines called antineoplastics. It interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected, other unwanted effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects may not be serious but may cause concern. Some effects may not occur until months or years after the medicine is used.

Before you begin treatment with paclitaxel, you and your doctor should talk about the good this medicine will do as well as the risks of using it.

This medicine is to be administered only by or under the immediate supervision of your doctor.

Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, paclitaxel is used in certain patients with the following medical conditions:

  • Cancer of the bladder.
  • Cancer of the cervix.
  • Cancer of the endometrium.
  • Cancer of the esophagus.
  • Cancer of the fallopian tube or lining of the abdomen (spreading from the ovary).
  • Cancers of the head and neck.
  • Cancer of the prostate.
  • Cancer of the stomach
  • Cancer of the testes.
  • Cancer of unknown primary site.
  • Small cell lung cancer (a certain type found in the tissues of the lungs).

This product is available in the following dosage forms:

  • Solution
Before Using
DR601051 Portions of this document last updated: Dec. 1, 2012

Source: Drug Information provided by: Micromedex

Copyright © 2013 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.

Advertisement


Text Size: smaller largerlarger